Kestra Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.67M Buy
2,901
+732
+34% +$742K 0.05% 106
2025
Q4
$2.33M Sell
2,169
-7
-0.3% -$6.69K 0.06% 125
2025
Q3
$1.66M Sell
2,176
-4,523
-68% -$3.37M 0.04% 140
2025
Q2
$5.37M Buy
6,699
+3,478
+108% +$2.7M 0.08% 84
2025
Q1
$2.66M Buy
3,221
+490
+18% +$408K 0.08% 79
2024
Q4
$2.11M Sell
2,731
-241
-8% -$200K 0.08% 81
2024
Q3
$2.63M Buy
+2,972
New +$2.67M 0.11% 70

Other funds holding LLY

Kestra Investment Management's LLY Position: Q1 2026 in Review

Kestra Investment Management increased its Eli Lilly (LLY) stake by 34% in Q1 2026, buying an estimated $742K and bringing the position to 2,901 shares worth $2.67M. The position accounts for 0.05% of the portfolio, ranked #106.

Kestra Investment Management first reported a position in LLY in Q3 2024 and has held it in 7 quarters since. The position peaked at $5.37M in Q2 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Kestra Investment Management held 2,901 shares of Eli Lilly worth $2.67M as of Q1 2026.
  • Kestra Investment Management bought 732 Eli Lilly shares in Q1 2026, an estimated $742K.
  • Eli Lilly made up 0.05% of Kestra Investment Management's portfolio in Q1 2026, its #106 holding.
  • Kestra Investment Management first reported a position in Eli Lilly in Q3 2024 and has held it in 7 quarters since.
  • Kestra Investment Management's Eli Lilly position peaked at $5.37M in Q2 2025.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Kestra Investment Management's 13F filing for Q1 2026, filed 11 May 2026.